Elon Musk sends fans into a frenzy as he unveils 'Ozempic Santa' look, shares childhood holiday photos

AUSTIN, TEXAS: Elon Musk is showing off his trimmed physique with a Christmassy twist.

The Tesla and SpaceX mogul dropped a photo of himself rocking a Santa Claus costume in front of a Christmas tree on Wednesday, December 25. But this wasn’t your ordinary jolly Saint Nick—this was “Ozempic Santa.”

Musk, who’s been vocal about his weight loss journey, revealed that he’s been taking Mounjaro — a drug designed to treat type-2 diabetes by lowering blood sugar levels.

Sharing the cheeky photo with his 150 million followers on X (formerly Twitter), he simply captioned it: “Ozempic Santa.”

In follow-up replies, Musk doubled down on the joke: “Like Cocaine Bear, but Santa and Ozempic! Technically, Mounjaro, but that doesn’t have the same ring to it.”

The billionaire also shared a childhood picture of himself dressed as Santa, holding a white bag, while drawing a comparison to his present festive attire and captioned the post "How it started vs how it’s going."

Social media’s roast and toast of Elon Musk's 'Ozempic Santa'

Of course, Elon Musk's fans on social media had to offer their two cents.

"If I had a girlfriend I would be sure to keep this picture far away from her," one posted on X.

"Damn you’ve shed a lot of pounds," another remarked.

"Santa skipped the cookies this year and hit the 'Hollywood diet.' Fit, festive, and ready to sleigh!" someone else gushed.

"Santa’s been chillin with the other hot older guy, @RobertKennedyJr! Couplah HUNKS!," read a comment.

A user stated, "This is how you go from rookie Santa to GOAT Santa."

"BRUH! I can’t have a skinny Santa. That’s like trusting an anorexic chef," another quipped.

One individual remarked, "Inspiring journey, Elon! Excited to see where it goes from here."

What’s the deal with Mounjaro and Ozempic?

There's an ongoing debate as to whether Mounjaro is just a weight loss fad or serious science.

The FDA approved the drug (also branded as Zepbound) in November last year for weight management in individuals struggling with obesity or being overweight. It’s part of a family of GLP-1 drugs, which also includes Ozempic and Wegovy.

Musk has been a vocal advocate for these medications, arguing they could revolutionize public health. On December 11, he posted on X: “Nothing would do more to improve the health, lifespan and quality of life for Americans than making [GLP-1 drugs] super low cost to the public. Nothing else is even close.”

Interestingly, Musk’s stance clashes with Robert F Kennedy Jr, who’s been critical of the growing reliance on weight loss drugs. After being nominated by President-elect Donald Trump to lead the Department of Health and Human Services, Kennedy Jr raised eyebrows with his bold takes.

Appearing on Greg Gutfeld’s late-night show in November, he slammed the costs and widespread use of drugs like Ozempic.

“We are spending $1.6k a month on this drug. There is a bill right now before Congress that will make it available to everybody who is overweight... that alone will cost $3 trillion a year," he explained. "If we spend about one-fifth of that giving good food, three meals a day, to every man, woman, and child in our country, we could solve the obesity and diabetes epidemic overnight.”

But Kennedy Jr’s tune shifted slightly after Musk—now one of Trump’s closest allies—publicly backed the drugs. In a December 12 interview with CNBC, Kennedy Jr softened his critique. “The first line of response should be lifestyle. It should be eating well, making sure you don’t get obese, and that those GLP drugs have a place," he conceded.

Meanwhile, rumors that Trump himself might be on Ozempic have swirled for months. Back in May, Joy Behar from 'The View' suggested Trump was using the drug after cohost Sunny Hostin commented on his slimmer appearance. 

This article contains remarks made on the Internet by individual people and organizations. MEAWW cannot confirm them independently and does not support claims or opinions being made online.